News
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...
19h
Everyday Health on MSNGLP-1s for Rheumatoid Arthritis: Can These Weight Loss Drugs Help With RA?Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.
12h
Health and Me on MSNDemand For Weight Loss Injections Now ‘Unsustainable’, Experts Say Most Don’t QualifyExperts warn that the surge in demand for weight loss injections like Ozempic and Wegovy is unsustainable, with most users ...
Caliway receives US FDA clearance to proceed with SUPREME-01 phase 3 study of CBL-514 for reducing abdominal subcutaneous fat: New Taipei City Tuesday, July 29, 2025, 14:00 Hrs [I ...
Researchers conducted the ACHIEVE-1 trial to assess the effect of orfoglipron on glycemic control among patients with early-stage type 2 diabetes.
There's been plenty of buzz about this class of drug, following publication of a high-profile trial this year. How much do we ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results